This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stephenson, J. S., U.K. Patent No.909,357.
Black, J. W., and Stephenson, J. S., Lancet, ii, 311 (1962).
Alcock, S. J., and Bond, P. A., Proc. European Soc. Study of Drug Toxitity, 4, 30 (1964).
Crowther, A. F., and Smith, L. H., U.K. Patent Applications Nos. 44357/62 and 44358/62.
Black, J. W., Crowther, A. F., Shanks, R. G., Smith, L. H., and Dornhurst, A. C., Lancet, i, 1080 (1964).
Personal communication from Dr. S. Baker .
Bond, P. A., and Howe, R., U.K. Patent Application No. 2437/64, and unpublished work.
Walpole, A. L., Roberts, D. C., Rose, F. L., Hendry, J. A., and Homer, R. F., Brit. J. Pharmacol., 9, 306 (1954).
Howe, R., U.K. Patent Applications Nos. 37597/61 and 37599/61.
Wolfheim, F., Ber., 47, 1451 (1914).
Crowther, A. F., Howe, R., and Smith, L. H., U.K. Patent Application No. 37598/61.
Howe, R., U.K. Patent Application No. 37600/61.
Ross, W. C. J., Biological Alkylating Agents, 101 (Butterworths, London, 1962).
Clayson, D. B., Brit. J. Cancer, 7, 460 (1953).
Walpole, A. L., Williams, M. H. C., and Roberts, D. C., Brit. J. Indust. Med., 9, 255 (1952).
Miller, J. A., Cramer, J. W., and Miller, E. C., Cancer Res., 20, 950 (1960).
Boyland, E., Dukes, C. E., and Grover, P. L., Brit. J. Cancer, 17, 79 (1963).
Miller, E. C., and Miller, J. A., Biochim. Biophys. Acta, 40, 380 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
HOWE, R. Carcinogenicity of ‘Alderlin’ (Pronethalol) in Mice*. Nature 207, 594–595 (1965). https://doi.org/10.1038/207594a0
Published:
Issue Date:
DOI: https://doi.org/10.1038/207594a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.